M. ÇAKIRCA Et Al. , "Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients," Drug Design, Development and Therapy , vol.8, pp.239-243, 2014
ÇAKIRCA, M. Et Al. 2014. Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients. Drug Design, Development and Therapy , vol.8 , 239-243.
ÇAKIRCA, M., KARATOPRAK, C., ZORLU, M., KISKAÇ, M., Kanat, M., Cikrikcioglu, M. A., ... SOYSAL, P.(2014). Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients. Drug Design, Development and Therapy , vol.8, 239-243.
ÇAKIRCA, MUSTAFA Et Al. "Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients," Drug Design, Development and Therapy , vol.8, 239-243, 2014
ÇAKIRCA, MUSTAFA Et Al. "Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients." Drug Design, Development and Therapy , vol.8, pp.239-243, 2014
ÇAKIRCA, M. Et Al. (2014) . "Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients." Drug Design, Development and Therapy , vol.8, pp.239-243.
@article{article, author={MUSTAFA ÇAKIRCA Et Al. }, title={Effect of vildagliptin add-on treatment to metformin on plasma asymmetric dimethylarginine in type 2 diabetes mellitus patients}, journal={Drug Design, Development and Therapy}, year=2014, pages={239-243} }